cmeadminuser

Effect of USP Sample Storage Conditions on Microbial Recovery from Tryptic Soy Agar (TSA) Plates Deanna L. Kiska1, Rebecca A. Moran1, and Chris Lee2 1U.S. Micro-Solutions, Inc., Latrobe, PA and 2EpiClear Consulting, Columbus, OH Introduction The United States Pharmacopeia (USP) – National Formulary (NF) has established minimum standards for the control and monitoring of sterile compounding facilities and aseptic processing […]

Legionnaire’s Disease may be a Threat after COVID-19 Restrictions Ease Is Your Building’s Water Safe for Returning Workers? By mid-March, workplaces were shutting down across America as States began issuing “stay at home” orders and all non-essential businesses closed their doors. The impact of the COVID-19 crisis will be with us for some time to come, but all of its […]

Hospitals and USP 797 Requirements Reducing Drug Contamination Risks USP <797>, from the United States Pharmacopeia, is a set of enforceable sterile compounding standards. It applies to compounding pharmacies and facilities involved in the preparation of compounded sterile preparations (CSPs). Within the last 5 years, 3 versions of USP <797> have been publicly available (2008, 2015 revision, 2019 revision).  This […]

USP 797 Environmental Monitoring Microbial Contamination Many health care providers, including hospitals, compounding pharmacies, and long-term care facilities maintain cleanrooms or segregated compounding areas for the sterile compounding of medications (CSPs). A critical concern in any compounding environment is microbial contamination of CSPs, which can cause harm or even death when administered to a patient. United States Pharmacopeia (USP) <797> […]